Cover Image
Market Research Report
Product code 
1031273

Global Cell Line Development Market 2021-2025

Published: | TechNavio (Infiniti Research Ltd.) | 120 Pages | Delivery time: 1-2 business days

Price

Back to Top
Global Cell Line Development Market 2021-2025
Published: August 3, 2021
TechNavio (Infiniti Research Ltd.)
Content info: 120 Pages
Delivery time: 1-2 business days
  • ALL
  • Description
  • Table of Contents
Description

Technavio has been monitoring the cell line development market and it is poised to grow by $ 4.39 bn during 2021-2025, progressing at a CAGR of 13.17% during the forecast period. Our report on the cell line development market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increased demand for monoclonal antibodies and patent expiration of drugs. In addition, increased demand for monoclonal antibodies is anticipated to boost the growth of the market as well.

The cell line development market analysis includes the product segment and geographic landscape.

Technavio's cell line development market is segmented as below:

By Product

  • Media and reagents
  • Equipment

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • ROW

This study identifies the rise in vaccines productionas one of the prime reasons driving the cell line development market growth during the next few years.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on cell line development market covers the following areas:

  • Cell line development market sizing
  • Cell line development market forecast
  • Cell line development market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading cell line development market vendors that include Cobra Biologics Ltd., Danaher Corp., Lonza Group Ltd., Merck KGaA, Molecular Devices LLC, Promega Corp., Sartorius AG, Selexis SA, Thermo Fisher Scientific Inc., and WuXi Biologics (Cayman) Inc. Also, the cell line development market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents
Product Code: IRTNTR70857

Table of Contents

  • Executive Summary
    • Market overview
  • Market Landscape
    • Market ecosystem
    • Value chain analysis
  • Market Sizing
    • Market definition
    • Market segment analysis
    • Market size 2020
    • Market outlook: Forecast for 2020 - 2025
  • Five Forces Analysis
    • Bargaining power of buyers
    • Bargaining power of suppliers
    • Threat of new entrants
    • Threat of substitutes
    • Threat of rivalry
    • Market condition
  • Market Segmentation by Product
    • Market segments
    • Comparison by Product
    • Media and reagents - Market size and forecast 2020-2025
    • Equipment - Market size and forecast 2020-2025
    • Market opportunity by Product
  • Customer landscape
    • Customer landscape
  • Geographic Landscape
    • Geographic segmentation
    • Geographic comparison
    • North America - Market size and forecast 2020-2025
    • Europe - Market size and forecast 2020-2025
    • Asia - Market size and forecast 2020-2025
    • ROW - Market size and forecast 2020-2025
    • Key leading countries
    • Market opportunity By Geographical Landscape
    • Market drivers
    • Market challenges
    • Market trends
  • Vendor Landscape
    • Overview
    • Landscape disruption
  • Vendor Analysis
    • Vendors covered
    • Market positioning of vendors
    • Cobra Biologics Ltd.
    • Danaher Corp.
    • Lonza Group Ltd.
    • Merck KGaA
    • Molecular Devices LLC
    • Promega Corp.
    • Sartorius AG
    • Selexis SA
    • Thermo Fisher Scientific Inc.
    • WuXi Biologics (Cayman) Inc.
  • Appendix
    • Scope of the report
    • Currency conversion rates for US$
    • Research methodology
    • List of abbreviations

Exhibits

  • 1: Key Finding 1
  • 2: Key Finding 2
  • 3: Key Finding 3
  • 4: Key Finding 5
  • 5: Key Finding 6
  • 6: Key Finding 7
  • 7: Key Finding 8
  • 8: Parent market
  • 9: Market characteristics
  • 10: Offerings of vendors included in the market definition
  • 11: Market segments
  • 12: Global - Market size and forecast 2020 - 2025 ($ million)
  • 13: Global market: Year-over-year growth 2020 - 2025 (%)
  • 14: Five forces analysis 2020 & 2025
  • 15: Bargaining power of buyers
  • 16: Bargaining power of suppliers
  • 17: Threat of new entrants
  • 18: Threat of substitutes
  • 19: Threat of rivalry
  • 20: Market condition - Five forces 2020
  • 21: Product - Market share 2020-2025 (%)
  • 22: Comparison by Product
  • 23: Media and reagents - Market size and forecast 2020-2025 ($ million)
  • 24: Media and reagents - Year-over-year growth 2020-2025 (%)
  • 25: Equipment - Market size and forecast 2020-2025 ($ million)
  • 26: Equipment - Year-over-year growth 2020-2025 (%)
  • 27: Market opportunity by Product
  • 28: Customer landscape
  • 29: Market share By Geographical Landscape 2020-2025 (%)
  • 30: Geographic comparison
  • 31: North America - Market size and forecast 2020-2025 ($ million)
  • 32: North America - Year-over-year growth 2020-2025 (%)
  • 33: Europe - Market size and forecast 2020-2025 ($ million)
  • 34: Europe - Year-over-year growth 2020-2025 (%)
  • 35: Asia - Market size and forecast 2020-2025 ($ million)
  • 36: Asia - Year-over-year growth 2020-2025 (%)
  • 37: ROW - Market size and forecast 2020-2025 ($ million)
  • 38: ROW - Year-over-year growth 2020-2025 (%)
  • 39: Key leading countries
  • 40: Market opportunity By Geographical Landscape ($ million)
  • 41: Impact of drivers and challenges
  • 42: Vendor landscape
  • 43: Landscape disruption
  • 44: Industry risks
  • 45: Vendors covered
  • 46: Market positioning of vendors
  • 47: Cobra Biologics Ltd. - Overview
  • 48: Cobra Biologics Ltd. - Product and service
  • 49: Cobra Biologics Ltd. - Key offerings
  • 50: Cobra Biologics Ltd. - Key customers
  • 51: Cobra Biologics Ltd. - Segment focus
  • 52: Danaher Corp. - Overview
  • 53: Danaher Corp. - Business segments
  • 54: Danaher Corp. - Key offerings
  • 55: Danaher Corp. - Key customers
  • 56: Danaher Corp. - Segment focus
  • 57: Lonza Group Ltd. - Overview
  • 58: Lonza Group Ltd. - Business segments
  • 59: Lonza Group Ltd. - Key offerings
  • 60: Lonza Group Ltd. - Key customers
  • 61: Lonza Group Ltd. - Segment focus
  • 62: Merck KGaA - Overview
  • 63: Merck KGaA - Business segments
  • 64: Merck KGaA - Key offerings
  • 65: Merck KGaA - Key customers
  • 66: Merck KGaA - Segment focus
  • 67: Molecular Devices LLC - Overview
  • 68: Molecular Devices LLC - Product and service
  • 69: Molecular Devices LLC - Key offerings
  • 70: Molecular Devices LLC - Key customers
  • 71: Molecular Devices LLC - Segment focus
  • 72: Promega Corp. - Overview
  • 73: Promega Corp. - Product and service
  • 74: Promega Corp. - Key offerings
  • 75: Promega Corp. - Key customers
  • 76: Promega Corp. - Segment focus
  • 77: Sartorius AG - Overview
  • 78: Sartorius AG - Business segments
  • 79: Sartorius AG - Key offerings
  • 80: Sartorius AG - Key customers
  • 81: Sartorius AG - Segment focus
  • 82: Selexis SA - Overview
  • 83: Selexis SA - Business segments
  • 84: Selexis SA - Key offerings
  • 85: Selexis SA - Key customers
  • 86: Selexis SA - Segment focus
  • 87: Thermo Fisher Scientific Inc. - Overview
  • 88: Thermo Fisher Scientific Inc. - Business segments
  • 89: Thermo Fisher Scientific Inc. - Key offerings
  • 90: Thermo Fisher Scientific Inc. - Key customers
  • 91: Thermo Fisher Scientific Inc. - Segment focus
  • 92: WuXi Biologics (Cayman) Inc. - Overview
  • 93: WuXi Biologics (Cayman) Inc. - Business segments
  • 94: WuXi Biologics (Cayman) Inc. - Key offerings
  • 95: WuXi Biologics (Cayman) Inc. - Key customers
  • 96: WuXi Biologics (Cayman) Inc. - Segment focus
  • 97: Currency conversion rates for US$
  • 98: Research Methodology
  • 99: Validation techniques employed for market sizing
  • 100: Information sources
  • 101: List of abbreviations